FDA Approves Benralizumab for EGPA Vasculitis Indication ...Middle East

Medscape - News
In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids. Medscape Medical News

Hence then, the article about fda approves benralizumab for egpa vasculitis indication was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Benralizumab for EGPA Vasculitis Indication )

Apple Storegoogle play

Last updated :

Also on site :